RET Fusion-Positive Thyroid Cancer
RET fusion-positive thyroid cancer represents a distinct molecular subset of differentiated thyroid cancers, predominantly papillary thyroid carcinoma (PTC) and poorly differentiated thyroid carcinoma (PDTC). RET
RET fusion-positive thyroid cancer represents a distinct molecular subset of differentiated thyroid cancers, predominantly papillary thyroid carcinoma (PTC) and poorly differentiated thyroid carcinoma (PDTC). RET
Differentiated thyroid carcinoma (DTC) is the most common type of thyroid malignancy, originating from follicular thyroid cells. It comprises two primary subtypes: papillary thyroid carcinoma